R&D Change Underlines Sanofi SA (SNY) Prospects as One of the Best Dividend Stocks to Buy

Sanofi SA (NASDAQ:SNY) is one of the best dividend stocks yielding at least 5% to buy according to hedge funds. On June 22, Sanofi SA (NASDAQ:SNY) announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President and Global Head of Research & Development Pharma, effective September 1. Based in Paris, Fontoura will [...]